LENSAR Inc. (LNSR)

Name: LENSAR Inc. (LNSR) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: LENSAR Inc. (LNSR)

Stock Card

$8.46

$0.07 (0.83%)

As on 01-Sep-2026 13:37EDT

Market cap

$102 Mln

Revenue (TTM)

$60 Mln

P/E Ratio

41.5

P/B Ratio

Div. Yield

0 %

LENSAR (LNSR) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 8.40 High: 8.56

52 Week Range

Low: 4.95 High: 12.94

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.4 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-1
Debt to Equity

0
Book Value

$--
EPS

$2.1
Face value

--
Shares outstanding

12,285,865

6 Years Aggregate

CFO

$-61.75 Mln

EBITDA

$-72.07 Mln

Net Profit

$-91.58 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
LENSAR (LNSR)	-27.3	68.9	45.9	-31.1	35.5	-1.0	--
BSE Sensex	-9.1	-1.5	2.9	-3.6	5.9	6.0	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 01-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021
LENSAR (LNSR)	30.1	152.8	18.6	-50.6	-17.4
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3
BSE Sensex	9.1	8.1	18.7	4.4	22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
LENSAR (LNSR)	8.5	102.0	60.3	34.7	52.9	--	41.5	7.0
10X Genomics Inc (TXG)	61.3	8,018.1	616.9	-75.1	1.7	-9.3	--	10.2
Avantor (AVTR)	14.4	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	56.1	8,696.7	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	176.1	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.9	6,577.5	1,556.3	275.3	24.6	22.9	24.1	5.0
Penumbra (PEN)	322.7	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	169.6	9,947.9	785.1	41.5	9.9	2	251.8	4.9
Smith & Nephew SNATS - ADR	29.1	12,153.4	6,164.0	625.0	13.0	11.8	19.9	2.4

Shareholding Pattern

View Details

About LENSAR (LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System,... Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. Read more

President, CEO & Director

Mr. Nicholas T. Curtis
President, CEO & Director

Mr. Nicholas T. Curtis
Headquarters

Orlando, FL
Website

https://www.lensar.com

FAQs for LENSAR (LNSR)

What is the current share price of LENSAR Inc (LNSR) Today?

The share price of LENSAR Inc (LNSR) is $8.46 (NASDAQ) as of 01-Sep-2026 13:37 EDT. LENSAR Inc (LNSR) has given a return of 35.51% in the last 3 years.

What is the current PB & PE ratio of LENSAR Inc (LNSR)?

The P/E ratio of LENSAR Inc (LNSR) is 41.50 times as on 28-Aug-2026, a 7 discount to its peers’ median range of 44.46 times.
The P/B ratio of LENSAR Inc (LNSR) is 6.98 times as on 28-Aug-2026, a 84 premium to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.